Summary
UnitedHealth Group (UNH) announced a significant leadership transition effective September 1, 2017. David S. Wichmann will be promoted from President to Chief Executive Officer (CEO) and join the Board of Directors. He will receive an increased base salary of $1,300,000, an annual cash incentive target of 200% of base salary, and equity awards including stock options, restricted stock units, and performance shares. Stephen J. Hemsley, the outgoing CEO, will transition to the role of Executive Chairman of the Board, with a reduced base salary of $1,000,000, ensuring continuity and leveraging his extensive experience. This transition marks a planned succession, with Richard T. Burke continuing as Lead Independent Director to support board oversight. The company also made adjustments to the employment agreements for Mr. Wichmann and Vice Chairman Larry Renfro, particularly concerning definitions of "Good Reason" to reflect their new or ongoing roles and responsibilities. Additionally, UNH amended its Bylaws to make the President position optional and to align with Delaware law regarding director voting, signaling organizational flexibility and good governance.
Key Highlights
- 1David S. Wichmann appointed CEO and Director, effective September 1, 2017.
- 2Stephen J. Hemsley transitions from CEO to Executive Chairman of the Board.
- 3Wichmann's compensation includes a $1.3 million base salary, 200% cash incentive target, and significant equity awards.
- 4Hemsley's base salary reduced to $1 million as Executive Chairman.
- 5Richard T. Burke will serve as Lead Independent Director, ensuring board oversight and continuity.
- 6Amendments to employment agreements for Wichmann and Larry Renfro provide clarity on 'Good Reason' definitions.
- 7Bylaws amended to make the President role optional and remove outdated director voting provisions.